Stock Rich List
#8092 on the rich list of 14,644 insiders

Richard S. Levy

Director at Madrigal Pharmaceuticals; Director at Kiniksa Pharmaceuticals International; Director at Protara Therapeutics.

$11.1M
in disclosed stock, −$61K (−0.54%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
8092nd of 14,644
Companies held
3
Largest holding
MDGL, 80.1% of total
Latest SEC filing
Aug 1, 2026

What the $11.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Madrigal Pharmaceuticals MDGL
Common Stock
Directly22,469$396.74$8.9M80.1%Form 4, Jun 17, 2026
Kiniksa Pharmaceuticals International KNSA
Class A Ordinary Share
Directly22,359$93.54$2.1M18.8%Form 4, Aug 1, 2026
Protara Therapeutics TARA
Common Stock
Directly51,000$2.40$122K1.1%Form 4/A, May 14, 2025

Share counts are the amounts Richard S. Levy reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
May 22, 2026SoldMDGL80$519.98$42KView
May 22, 2026SoldMDGL782$518.76$406KView
May 22, 2026SoldMDGL1,497$517.59$775KView
May 22, 2026SoldMDGL723$516.87$374KView
May 22, 2026SoldMDGL657$515.92$339KView
May 22, 2026SoldMDGL343$514.67$177KView
May 22, 2026SoldMDGL40$512.97$21KView
May 22, 2026SoldMDGL439$512.50$225KView
May 22, 2026SoldMDGL610$511.40$312KView
May 22, 2026SoldMDGL151$510.36$77KView
May 22, 2026SoldMDGL40$506.68$20KView
May 22, 2026SoldMDGL320$508.24$163KView
Nov 13, 2025SoldMDGL146$514.67$75KView
Nov 13, 2025SoldMDGL919$515.64$474KView
Nov 13, 2025SoldMDGL645$517.51$334KView
Nov 13, 2025SoldMDGL835$518.53$433KView
Nov 13, 2025SoldMDGL1,355$519.67$704KView
Nov 13, 2025SoldMDGL308$520.68$160KView
Nov 13, 2025SoldMDGL1,094$521.79$571KView
Nov 13, 2025SoldMDGL1,434$522.70$750KView
Nov 13, 2025SoldMDGL811$523.66$425KView
Nov 13, 2025SoldMDGL153$524.49$80KView
Nov 13, 2025SoldMDGL120$526.68$63KView
Nov 13, 2025SoldMDGL200$527.85$106KView
Nov 13, 2025SoldMDGL440$528.60$233KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
8089Siddharth N. Mehta
Director, Jones Lang LaSalle. Chicago, IL
$11.1M−$239K (−2.10%)
8090Michael P. Dempsey
Executive Officer, Bank First. Manitowoc, WI
$11.1M−$124K (−1.10%)
8091Wanjiku Juanita Walcott
Chief Legal & Bus Affairs Ofc., Pinterest. San Francisco, CA
$11.1M−$527K (−4.52%)
8092Richard S. Levy
Director, Madrigal Pharmaceuticals
$11.1M−$61K (−0.54%)
8093Michael Patrick Shanley
Sr. VP, Operations, Reliance. Los Angeles, CA
$11.1M−$132K (−1.17%)
8094Matthew R. Miller
Director, Granite Ridge Resources. Dallas, TX
$11.1M−$218K (−1.92%)
8095Scott C. Darling
Director, Zscaler. San Jose, CA
$11.1M+$426K (+3.98%)

Other Madrigal Pharmaceuticals insiders

All MDGL insiders

Questions

How much stock does Richard S. Levy own?

Richard S. Levy holds $11,128,100 in listed stock based on SEC filings and current prices, mostly Madrigal Pharmaceuticals (MDGL). That ranks 8092nd on the Stock Rich List.

Is this Richard S. Levy's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Richard S. Levy last buy or sell stock?

The most recent open-market trade on file is a sale of 80 MDGL shares on May 22, 2026 at $519.98.